ArticleNeuro-oncology2023
Erratum to: EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.